[1] |
Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19. 1 million participants from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19.1 million participants[J]. Lancet, 2017, 389(10064):37-55.
doi: 10.1016/S0140-6736(16)31919-5
URL
|
[2] |
Contributions of mean and shape of blood pressure distribution to worldwide trends and variations in raised blood pressure: A pooled analysis of 1018 population-based measurement studies with 88.6 million participants[J]. Int J Epidemiol, 2018, 47(3):872-883i.
doi: 10.1093/ije/dyy016
URL
|
[3] |
Brewster LM, Clark JF, Van Montfrans GA. Is greater tissue activity of creatine kinase the genetic factor increasing hypertension risk in black people of sub-Saharan African descent?[J]. J Hypertens, 2000, 18(11):1537-1544.
pmid: 11081764
|
[4] |
Haan YC, Oudman I, Diemer F S, et al. Creatine kinase as a marker of obesity in a multi-ethnic population[J]. Mol Cell Endocrinol, 2017, 442:24-31.
doi: 10.1016/j.mce.2016.11.022
URL
|
[5] |
Brewster LM. Creatine kinase, energy reserve, and hypertension: From bench to bedside[J]. Ann Transl Med, 2018, 6(15):292.
doi: 10.21037/atm.2018.07.15
pmid: 30211180
|
[6] |
Ingwall JS. Energy metabolism in heart failure and remodelling[J]. Cardiovasc Res, 2008, 81(3):412-419.
doi: 10.1093/cvr/cvn301
URL
|
[7] |
Brewster LM. Extracellular creatine kinase may modulate purinergic signalling[J]. Purinergic Signal, 2020, 16(3):305-312.
doi: 10.1007/s11302-020-09707-0
URL
|
[8] |
Brewster LM, Fernand J. Creatine kinase is associated with bleeding after myocardial infarction[J]. Open Heart, 2020, 7(2):e001261.
doi: 10.1136/openhrt-2020-001261
URL
|
[9] |
Brewster LM, Mairuhu G, Bindraban NR, et al. Creatine kinase activity is associated with blood pressure[J]. Circulation, 2006, 114(19):2034-2039.
pmid: 17075013
|
[10] |
Pisoni R, Hamrahian M, Fülöp T. Creatine kinase, sodium retention, and blood pressure: Is there a link?[J]. J Clin Hypertens (Greenwich), 2018, 20(2):342-344.
doi: 10.1111/jch.2018.20.issue-2
URL
|
[11] |
Oudman I, Kewalbansingh PV, Van Valkengoed I, et al. Creatine kinase is associated with failure of hypertension treatment[J]. J Hypertens, 2013, 31(5):1025-1031.
doi: 10.1097/HJH.0b013e32835f5c29
pmid: 23466941
|
[12] |
Brewster LM, Seedat YK. Why do hypertensive patients of African ancestry respond better to calcium blockers and diuretics than to ACE inhibitors and β- adrenergic blockers? A systematic review[J]. BMC Med, 2013, 11:141.
doi: 10.1186/1741-7015-11-141
pmid: 23721258
|
[13] |
Brewster LM, Haan YC, Zwinderman AH, et al. Creatine kinase and renal sodium excretion in African and European men on a high sodium diet[J]. J Clin Hypertens (Greenwich), 2018, 76(2):373-380.
|
[14] |
Schiaffino S, Reggiani C. Fiber types in mammalian skeletal muscles[J]. Physiol Rev, 2011, 91(4):1447-1531.
doi: 10.1152/physrev.00031.2010
pmid: 22013216
|
[15] |
Brewster LM, Coronel CM, Sluiter W, et al. Ethnic differences in tissue creatine kinase activity: An observational study[J]. PLoS One, 2012, 7(3):e32471.
doi: 10.1371/journal.pone.0032471
URL
|
[16] |
Brewster LM, Van Montfrans GA. Creatinine kinase and hypertension[J]. J Clin Hypertens (Greenwich), 2008, 10(6):506.
doi: 10.1111/j.1751-7176.2008.tb00001.x
URL
|
[17] |
Johnsen SH, Lilleng H, Wilsgaard T, et al. Creatine kinase activity and blood pressure in a normal population: The Tromsø study[J]. J Hypertens, 2011, 29(1):36-42.
doi: 10.1097/HJH.0b013e32834068e0
pmid: 21063205
|
[18] |
Yen CH, Wang KT, Lee PY, et al. Gender-differences in the associations between circulating creatine kinase, blood pressure, body mass and non-alcoholic fatty liver disease in asymptomatic Asians[J]. PLoS One, 2017, 12:e0179898.
|
[19] |
Emokpae MA, Nwagbara G. Serum creatine kinase-MB isoenzyme activity among subjects with uncomplicated essential hypertension: Any sex differences[J]. Med Sci(Basel), 2017, 5(2):8.
|
[20] |
Brewster LM, Karamat FA, Van Montfrans GA. Creatine kinase and blood pressure: A systematic review[J]. Med Sci (Basel), 2019, 7(4):58.
|
[21] |
Horjus DL, Bokslag A, Hooijberg F, et al. Creatine kinase and blood pressure in women with a history of early-onset preeclampsia[J]. Pregnancy Hypertens, 2019, 15:118-122.
doi: 10.1016/j.preghy.2018.12.009
URL
|
[22] |
Brewster LM, Haan YC, Zwinderman AH, et al. CK (creatine kinase) is associated with cardiovascular hemodynamics: The HELIUS study[J]. Hypertension, 2020, 76(2):373-380.
doi: 10.1161/HYPERTENSIONAHA.120.14675
pmid: 32594803
|
[23] |
Oudman I, Clark JF, Brewster LM. The effect of the creatine analogue beta-guanidinopropionic acid on energy metabolism: A systematic review[J]. PLoS One, 2013, 8(1):e52879.
doi: 10.1371/journal.pone.0052879
URL
|
[24] |
Karamat FA, Oudman I, Haan YC, et al. Creatine kinase inhibition lowers systemic arterial blood pressure in spontaneously hypertensive rats: A randomized controlled trial[J]. J Hypertens, 2016, 34(12):2418-2426.
pmid: 27512977
|
[25] |
Fares AK, Deborah LH, Yentl CH, et al. The acute effect of beta-guanidinopropionic acid versus creatine or placebo in healthy men (ABC-trial): A randomized controlled first-in-human trial[J]. Br J Clin Pharmacol, 2017, 83(12):2626-2635.
doi: 10.1111/bcp.v83.12
URL
|